IBRX SG&A Expense Growth
Immunitybio Inc · SG&A Expense Growth
IBRX SG&A Expense Growth
Latest reported-12.80%period ending
IBRX FY SG&A Growth (YoY) (0.00% → -12.80%)
Latest values, visible window
High-resolution chart · PNG
IBRX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -12.7993% | |
| 30.2137% | |
| 26.2024% | |
| -24.064% | |
| 89.652% | |
| 687.7831% | |
| -74.472% | |
| -34.1094% | |
| -42.9808% | |
| -58.2721% | |
| 5,128.9875% | |
| 78.8342% | |
| 0% |